REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/07/2026
Voltar para busca
Dado oficial do USPTO
RTM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
65
Atualização mais recente
11/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
14/08/2015
Data de registro
11/07/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/07/2023
Última transação
11/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Schlieren, CH
Examinador
VALLILLO, MELISSA C
Unidade examinadora
L50
Titulares e representantes
Titulares
Neurimmune Holding AG
Neurimmune Holding AG
Representantes
Janice Housey Litmus Law PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry; chemical preparations for industrial purposes; chemical preparations for scientific use other than for medical or veterinary use; chemical preparations for photography; biological materials other than for medical or veterinary purposescell culturestissue cultureschemical and biological assays; biological preparations for use in cell cultures other than for medical or veterinary use; peptides for chemical products and foodstuffspeptide substrates used in analyzing and detecting certain toxins for laboratory or research use; polypeptides for use in diagnostic and therapeutic agents except for medical or veterinary use; antibodies and proteins for scientific use
Classe 5
Pharmaceutical preparations for use in the treatment of diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations for use in the treatment of diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for the removal of tumors; pharmaceutical preparations for neurodegenerative diseases; pharmaceutical preparationsimmunogens for medical use; vaccinesdiagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological disease; epitopes for pharmaceutical use for use in attaching to antibodies for in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological disease; peptides for pharmaceutical purposes for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; sanitary preparations for medical use; biological preparations for medical usepharmaceutical preparations for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; biocides; diagnostic productsdiagnostic preparations for medical and veterinary use; pre-moistened medicated towels for hygiene purposes; dietetic foodsgluten-free foodlow-sodium foodlow-calorie or reduced calorie food for weight reduction adapted for medical purposesdietetic bread and dietetic noodles; dietetic beveragesgluten-free beverageslow-sodium beveragesdietetic tea adapted for medical use; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposeslow calorie or reduced calorie fruit beverages; protein antibodies for medical purposesdiagnostic kits consisting primarily of monoclonal antibodies for use in disease testing
Classe 42
Monitoring and inspection for the quality control and scientific analysis of active substances; pharmaceutical research; scientific research in the field of cosmetics and foodstuffs; consultancy and information on monitoring and inspection for the quality control and scientific analysis of active substances; scientific consultation relating to research involving pharmaceutical products; scientific consultation relating to research in the field of cosmetics and foodstuffs; monitoring and inspection for the quality control and scientific analysis of active substances; scientific research involving medical treatment and methods; scientific research in the fields of biotechnology and antibodies; information on monitoring and inspection for the quality control and scientific analysis of active substance; scientific testing and research in technical and medical treatment relating to active substances; scientific research in the field of sanitary care; scientific monitoringinspection and research in the field of biology; consultancy and provision of information relating to quality control of pharmaceutical preparations; software maintenancecomputer software designcomputer programming; design and development of computer hardware; software development; software maintenance; all of the foregoing related to pharmaceutical preparationsmedical and veterinary purposes and related to the treatmentdiagnosis and prevention of human diseases
Classe 44
Medical services; medical services in the field of immunity; provision of medical information; medical examinations; preparation and dispensing of medicines; nutritional consultancy and dietary consultancy relating to nutrition; medical consultancy and provision of medical information in the field of sanitary care; veterinary servicesveterinary assistance; beauty salon services; veterinary care services for animals; hygienic care; consultancy and provision of information relating to the dispensing and preparation of pharmaceutical preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
65 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/07/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
06/05/2024
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
20/03/2024
INPC
INVALIDATION PROCESSED
20/03/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/03/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/07/2023
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/07/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2023
ES75
TEAS SECTION 71 & 15 RECEIVED
15/12/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/03/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/11/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/10/2017
FIMP
FINAL DISPOSITION PROCESSED
16/10/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/10/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
16/06/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
31/05/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
31/05/2017
PUBO
PUBLISHED FOR OPPOSITION
25/04/2017
GPNX
NOTIFICATION PROCESSED BY IB
22/04/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2017
NPUB
NOTICE OF PUBLICATION
05/04/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
20/03/2017
EXPT
EXPARTE APPEAL TERMINATED
15/03/2017
CNEA
EXAMINERS AMENDMENT MAILED
15/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/03/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
15/03/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2017
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2017
ALIE
ASSIGNED TO LIE
06/02/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/01/2017
EXPI
EX PARTE APPEAL-INSTITUTED
19/01/2017
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
19/01/2017
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
19/01/2017
CNFR
FINAL REFUSAL MAILED
19/07/2016
CNFR
FINAL REFUSAL WRITTEN
19/07/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/06/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/06/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/06/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/03/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/03/2016
RFNT
REFUSAL PROCESSED BY IB
01/02/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/01/2016
RFRR
REFUSAL PROCESSED BY MPU
11/01/2016
MAFR
APPLICATION FILING RECEIPT MAILED
08/01/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/01/2016
CNRT
NON-FINAL ACTION WRITTEN
05/01/2016
DOCK
ASSIGNED TO EXAMINER
04/01/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RTM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.